MoonLake Immunotherapeutics (MLTX:NASDAQ) closed at $11.25 on November 17, 2026, down 4.09% on the day. The stock trades 51.7% below its 52-week high of $23.29 and 18.9% above its 52-week low of $9.46. Over the past year, it lost 12.5%. MoonLake Immunotherapeutics is part of the Funds & Shells sector.
In 252 trading sessions since November 17, 2025, MLTX closed higher on 115 days (46%). Its best day was January 9, 2026 (+28.94%) and its worst was April 1, 2026 (-11.37%). The stock moved 10% or more in a single session 9 times. It opened at least 5% above the previous day's high 1 time.
Helix Acquisition Corp is a blank check company.
Find more stocks like MLTX with the Spikes, Gaps, Breakouts and Performance Tracker scanners.
Based on end-of-day data. For information only, not investment advice.